Journal of applied physiology
-
Clinical Trial Controlled Clinical Trial
Inhibition of shivering increases core temperature afterdrop and attenuates rewarming in hypothermic humans.
During severe hypothermia, shivering is absent. To simulate severe hypothermia, shivering in eight mildly hypothermic subjects was inhibited with meperidine (1.5 mg/kg). Subjects were cooled twice (meperidine and control trials) in 8 degrees C water to a core temperature of 35.9 +/- 0.5 (SD) degrees C, dried, and then placed in sleeping bags. ⋯ This was likely due to the increased thermoregulatory drive with the greater afterdrop and the short half-life of meperidine. These results demonstrate the effectiveness of shivering heat production in attenuating the postcooling afterdrop of core temperature and potentiating core rewarming. The meperidine protocol may be valuable for comparing the efficacy of various hypothermia rewarming methods in the absence of shivering.
-
A dual direct/indirect room-sized calorimeter is used at the Beltsville Human Nutrition Research Center to measure heat emission and energy expenditure in humans. Because the response times of a gradient layer direct calorimeter and an indirect calorimeter are not equivalent, the respective rate of heat emission and energy expenditure cannot be directly compared. A system of equations has been developed and tested that can correct the respective outputs of the direct gradient layer calorimeter and indirect calorimeter for delays due to the response times of the measurement systems. ⋯ However, heat emission measured during sleep was significantly greater (14%) than energy expenditure, suggesting a change in the energy stored as heat in the body. This difference was reversed during the day. These results illustrate how the simultaneous measurement of heat emission and energy expenditure provides insights into heat regulation.
-
Comparative Study Clinical Trial Controlled Clinical Trial
Efficacy of forced-air and inhalation rewarming by using a human model for severe hypothermia.
We recently developed a nonshivering human model for severe hypothermia by using meperidine to inhibit shivering in mildly hypothermic subjects. This thermal model was used to evaluate warming techniques. On three occasions, eight subjects were immersed for approximately 25 min in 9 degrees C water. ⋯ The core temperature afterdrop was 30-40% less during forced-air warming (0.9 degree C) than during control (1.4 degrees C) and inhalation rewarming (1.2 degrees C) (P < 0.05). Rewarming rate was 6- to 10-fold greater during forced-air warming (2.40 degrees C/h) than during control (0.41 degree C/h) and inhalation rewarming (0.23 degree C/h) (P < 0.05). In nonshivering hypothermic subjects, forced-air warming provided a rewarming advantage, but inhalation rewarming did not.
-
Clinically, a noninvasive measure of diaphragm function is needed. The purpose of this study is to determine whether ultrasonography can be used to 1) quantify diaphragm function and 2) identify fatigue in a piglet model. Five piglets were anesthetized with pentobarbital sodium and halothane and studied during the following conditions: 1) baseline (spontaneous breathing); 2) baseline + CO2 [inhaled CO2 to increase arterial PCO2 to 50-60 Torr (6.6-8 kPa)]; 3) fatigue + CO2 (fatigue induced with 30 min of phrenic nerve pacing); and 4) recovery + CO2 (recovery after 1 h of mechanical ventilation). ⋯ Mean inspiratory velocity also decreased from 13 +/- 2 to 8 +/- 1 cm/s during these conditions. All variables returned to baseline during recovery + CO2. Ultrasonography can be used to quantify diaphragm function and identify piglet diaphragm fatigue.